EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Efficacy and Safety of Direct Oral Anti‐Coagulants in Painful Venous Malformations in Children

Olivia Boccara iD, Julie Bonigen, Véronique Soupre, Eve Puzenat, Annouk Bisdorff, Ludovic Drouet

Pediatric Dermatology · 2025-09 · 42 (5) · 1020-1023

DOI: 10.1111/pde.15930 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Dermatology, online erschienen am 09.04.2025. Verfasst von Olivia Boccara und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Reference Center for Genodermatoses and Rare Skin Diseases (MAGEC), AP-HP, Paris University, Necker-Enfants Malades Hos…. Hauptthemen laut MEDLINE: Anticoagulants, Vascular Malformations, Pain, Veins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Direct oral anticoagulants (DOAC), including dabigatran, apixaban, and rivaroxaban, are increasingly used in adults for painful venous malformations (VMs) instead of subcutaneous drugs such as low molecular weight heparins or fondaparinux. However, these medications are poorly studied in children. In seven children with painful VMs and chronic intravascular consumptive coagulopathy, DOACs allowed for successful pain control and improvement in coagulopathy, with no adverse effects. DOACs appear to be an effective alternative in childhood VM associated with intravascular coagulopathy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticoagulantsVascular MalformationsPainVeinsHumansChildMaleFemaleAdministration, OralChild, PreschoolAdolescentTreatment OutcomeRetrospective Studies

Stichwörter der Autor:innen

chronic consumptive coagulopathydirect oral anticoagulantlow molecular weight heparinvenous malformation

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Department of Dermatology and Reference Center for Genodermatoses and Rare Skin Diseases (MAGEC), AP-HP, Paris University, Necker-Enfants Malades Hospital, Paris Centre University, Imagine Institute, Paris, France.
  • Department of Maxillo-Facial and Plastic Surgery, Necker Hospital, Paris Centre University, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France.
  • Department of Dermatology, University Hospital of Besançon, Besançon, France.
  • Reference Center for Vascular Anomalies FAVA-Multi, University Hospital of Lariboisière, Paris, France.
  • Anticoagulation Clinic (CREATIF), Cardiology Department, Lariboisière Hospital, AP-HP, Paris, France.

ORCID-Profile: Olivia Boccara

Zitieren

APA

Boccara, O., Bonigen, J., Soupre, V., Puzenat, E., Bisdorff, A., & Drouet, L. (2025). Efficacy and Safety of Direct Oral Anti‐Coagulants in Painful Venous Malformations in Children. Pediatric Dermatology, 42(5), 1020-1023. https://doi.org/10.1111/pde.15930

Vancouver

Boccara O, Bonigen J, Soupre V, Puzenat E, Bisdorff A, Drouet L. Efficacy and Safety of Direct Oral Anti‐Coagulants in Painful Venous Malformations in Children. Pediatric Dermatology. 2025;42(5):1020-1023. doi:10.1111/pde.15930

BibTeX
@article{Boccara2025,
  author = {Boccara, Olivia and Bonigen, Julie and Soupre, Véronique and Puzenat, Eve and Bisdorff, Annouk and Drouet, Ludovic},
  title = {Efficacy and Safety of Direct Oral Anti‐Coagulants in Painful Venous Malformations in Children},
  journal = {Pediatric Dermatology},
  year = {2025},
  volume = {42},
  number = {5},
  pages = {1020--1023},
  doi = {10.1111/pde.15930}
}
Kostenlos starten →